Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

The FDA brings real-world data head to head with clinical trials

Nature Medicine volume 26, pages 302–303 (2020)Cite this article

The FDA launches the RCT DUPLICATE project to develop guidelines on using medical-claims data to expand drug labels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Patorno, E., Schneeweiss, S., Gopalakrishnan, C., Martin, D. & Franklin, J. M. Diabetes Care https://care.diabetesjournals.org/content/early/2019/06/19/dc19–0069 (2019).

  2. Rosenstock, J. et al. J. Am. Med. Assoc. 322, 1155–1166 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cambridge, MA, USA

    Monique Brouillette

Authors
  1. Monique Brouillette
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monique Brouillette.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brouillette, M. The FDA brings real-world data head to head with clinical trials. Nat Med 26, 302–303 (2020). https://doi.org/10.1038/s41591-020-0772-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-020-0772-0

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing